“…The ligand–VDR complex then interacts with the retinoid X receptor to form a heterodimer, which binds, with the assistance of cofactors, to specific regions of the DNA to induce the formation of proteins, which are responsible for a wide range of biological functions including the regulation of mineral homeostasis, cell differentiation-proliferation, apoptosis, and the immune system. − Despite the wide range of biological activities, the clinical applications of the hormone 1,25D 3 have been limited due to its collateral hypercalcemic effects . This problem has sparked interest in the development of less hypercalcemic and more selective 1,25D 3 analogues for the treatment of hyperproliferative diseases, and a few synthetic noncalcemic analogues are already being successfully used in the treatment of psoriasis. − Most of the 1,25D 3 analogues developed to date are modified in the side chain and A-ring, but only a few having structural alterations in the C-ring and/or D-ring have been developed due to synthetic difficulties. − Biological studies on 1,25D 3 analogues that lack the D-ring, − C-ring, ,− the bicyclic CD-ring, − or are modified on the C- or D-rings ,− show that the native CD-core is not mandatory for biological activity and its alteration can reduce the calcemic activity.…”